N	Concordance
1	ts. In the colon, the "toxicology" of 5 fluorouracil (5FU) is entirely dependent
2	N TI  - Ambulatory chronotherapy with 5-fluorouracil (5 FU), folinic acid (FOL) 
3	phase II study of continuous infusion 5-fluorouracil (5-FU) with epirubicin and 
4	        the maximum tolerable dose of 5-fluorouracil (5-FU) administered as a   
5	r (ARTCCB). An alternative regimen of 5-fluorouracil (5-FU) and cisplatin was ev
6	apy in combination with cisplatin and 5-fluorouracil (5-FU) chemotherapy at the 
7	 infusion cisplatin 25 mg/m2/day 1-5, 5-fluorouracil 800 mg/m2/day 2-5, and high
8	upport in combination with fixed-dose 5-fluorouracil and leucovorin in women wit
9	ot total recurrences. Intraperitoneal 5-fluorouracil does not significantly decr
10	orectal cancer, the concentrations of 5-fluorouracil in whole blood were 108-111
11	 known that the patient's response to 5-fluorouracil is very different concernin
12	studied the effect of anticancer drug 5-fluorouracil on the expression of human 
13	 combination of protracted infusional 5-fluorouracil (PIF) and cisplatin. We sou
14	-fluorocytosine to the antimetabolite 5-fluorouracil, also has been used in some
15	 of cyclophosphamide, methotrexate, and fluorouracil (CMF) for patients who wil
16	se rate and toxic effects of continuous fluorouracil in  patients with recurrent
17	 receive 1 week of  continuous-infusion fluorouracil (5-FU) perioperatively vs. 
18	aluate the effect of different doses of fluorouracil on toxicity in  these patie
19	  infusion of floxuridine plus systemic fluorouracil/leucovorin calcium in  pati